Mark Lewis, Director of Gastrointestinal Oncology at Intermountain Healthcare in Utah, posted on X:
“We need to bring biomarker testing in GI cancer up to the same standard we apply in breast cancer (where patients themselves are savvy enough to know and self-sort by receptor status).
Excellent summary of contemporary testing of gastric cancer at ASCO GI 2025.”
